Rituximab, Alemtuzumab, Daclizumab: New Research
The American Academy of Neurology had its annual meeting recently, where the newest in research is presented with the hope of better treatments. At this year's meeting, we heard a lot about updates of clinical trials we are all becoming familiar with: Rituximab - the monoclonal antibody directed against B cells. You will remember that... Read more
